Life sciences
By Emmanuelle Trombe, co-head of McDermott Will & Schulte's Life Sciences industry practice The life sciences and healthcare sector is entering a new phase marked by both increased complexity and significant opportunity. While it remains one of the most resilient and value-generating industries globally, the conditions underpinning that success are evolving. Recent discussions, including those [...]
In this episode of the Health Tech World Podcast, host Gordon speaks with Kathleen van Vlierberghe, Vice President for EMEA Peripheral Intervention at Boston Scientific, about how kidney cancer care in the UK is evolving. Together, they explore the impact of the first-ever NICE kidney cancer guidelines, why minimally invasive treatments like cryoablation remain underused [...]
An £11m digital twins centre will model organs and disease to speed drug discovery and help target medicines more precisely. The Modelling-Informed Medicine Centre, or MiMeC, will build computer models of organs and diseases to better understand how diseases of the lungs, liver and kidneys progress. Digital twins are virtual versions of organs that let [...]
A new daily pill could offer a more effective oral GLP-1 option for weight loss, according to a clinical trial that may open the door to an improved non-injection alternative to Wegovy and Mounjaro. The drug, orforglipron, manufactured by Eli Lilly and prescribed for type 2 diabetes, targets the same GLP-1 receptors as oral semaglutide. [...]
Illumina has completed its acquisition of proteomics company SomaLogic, expanding its multiomics portfolio. Proteomics is the large-scale study of proteins and how they function in the body. Analysing proteins in biological samples can reveal disease processes that genomics, the study of DNA, may not show on its own. Multiomics combines several biological approaches, such as [...]
An innovative quantum sensing project that could transform cancer treatment by tracking how immune cells interact with tumours has been awarded a £2 million Future Leaders Fellowship. The four-year fellowship, funded by UK Research and Innovation (UKRI), focuses on a critical problem: immune cells often fail when they encounter cancer tissue because the tumour environment [...]
Canadian life insurer and asset manager Manulife has boosted its presence in the healthy ageing sector with the launch of a CA$350m Longevity Institute. Valued at US$60bn, Manulife has been active in the longevity space for some time and says the new institute will see it fund ‘innovative research, and key industry collaborations’. Manulife’s chief [...]
Scotland has set out a life sciences strategy aimed at growing the sector to £25bn by 2035. The Scottish Government’s refreshed Life Sciences Strategy focuses on infrastructure and skills, and brings in technologies such as artificial intelligence. An initial £1m will support delivery. Business minister Richard Lochhead, who launched the strategy at Dundee [...]
By McDermott Will & Schulte European life sciences businesses have been closely tracking geopolitics and global policy changes over the past 12 months, particularly as the new administration in the United States heightens its focus on drug pricing. Against this backdrop, hundreds of healthcare professionals, investors, and industry changemakers gathered in London for McDermott Will [...]
The British Business Bank has committed €30m to Sofinnova Partners’ €650m life sciences fund, Sofinnova Capital XI. The fund will support early-stage biopharmaceutical and medical technology companies developing treatments for unmet medical needs, with initial and follow-on investments as firms grow. The commitment supports the UK’s Life Sciences Sector Plan and builds on the bank’s [...]
